Literature DB >> 14645692

Cell cycle regulation in patients with intestinal metaplasia at the gastro-oesophageal junction.

N J Trudgill1, S K Suvarna, J A Royds, S A Riley.   

Abstract

BACKGROUND/AIMS: The incidence of oesophageal adenocarcinoma is increasing rapidly and this may be related to the presence of intestinal metaplasia (IM) at the gastro-oesophageal junction (GOJ). Recent studies have distinguished two subtypes of IM at the GOJ: short segment Barrett's oesophagus (SSBO) and IM at a normal squamo-columnar junction (IMNSCJ). Because abnormal expression of cell cycle regulators is common in cancer and precancerous states, cell cycle regulation was studied in patients with IM at the GOJ.
METHODS: Biopsy samples and resected materials were identified from patients with SSBO (10), IMNSCJ (14), a normal SCJ with (14) and without (12) inflammation, conventional Barrett's oesophagus (BO) (12), and oesophageal adenocarcinoma (12). Sections were stained with antibodies to p21, p27, p53, Ki67, cyclin D1, and c-erbB2 and were assessed independently by two observers, using predetermined criteria.
RESULTS: Patients with oesophageal adenocarcinoma showed high expression of c-erbB2, p53, p27, and Ki67. Patients with BO showed expression of c-erbB2 but little expression of other markers. Greatly increased expression of cyclin D1 was seen in patients with IMNSCJ. The expression of all other markers was similar in patients with IMNSCJ and those with SSBO. Cyclin D1 and c-erbB-2 were coexpressed in patients with SSBO and IMNSCJ, and their expression was associated with the presence of p53 and p21.
CONCLUSIONS: Although the proposed aetiologies of SSBO (gastro-oesophageal reflux) and IMNSCJ (Helicobacter pylori infection) differ, the cell cycle response is similar and both may have malignant potential.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14645692      PMCID: PMC1187347          DOI: 10.1136/mp.56.6.313

Source DB:  PubMed          Journal:  Mol Pathol        ISSN: 1366-8714


  30 in total

1.  Effect of elimination of acid reflux on epithelial cell proliferative activity of Barrett esophagus.

Authors:  F T Peters; S Ganesh; E J Kuipers; W J Sluiter; A Karrenbeld; A de Jager-Krikken; E C Klinkenberg-Knol; C B Lamers; J H Kleibeuker
Journal:  Scand J Gastroenterol       Date:  2000-12       Impact factor: 2.423

2.  Flow-cytometric and histological progression to malignancy in Barrett's esophagus: prospective endoscopic surveillance of a cohort.

Authors:  B J Reid; P L Blount; C E Rubin; D S Levine; R C Haggitt; P S Rabinovitch
Journal:  Gastroenterology       Date:  1992-04       Impact factor: 22.682

3.  Adenocarcinomas arising in tongues or short segments of Barrett's esophagus.

Authors:  T G Schnell; S J Sontag; G Chejfec
Journal:  Dig Dis Sci       Date:  1992-01       Impact factor: 3.199

4.  Similarity of protein encoded by the human c-erb-B-2 gene to epidermal growth factor receptor.

Authors:  T Yamamoto; S Ikawa; T Akiyama; K Semba; N Nomura; N Miyajima; T Saito; K Toyoshima
Journal:  Nature       Date:  1986 Jan 16-22       Impact factor: 49.962

Review 5.  Malignant progression in Barrett's esophagus: pathology and molecular biology.

Authors:  J Mueller; M Werner; J R Siewert
Journal:  Recent Results Cancer Res       Date:  2000

6.  Helicobacter pylori activates the cyclin D1 gene through mitogen-activated protein kinase pathway in gastric cancer cells.

Authors:  Y Hirata; S Maeda; Y Mitsuno; M Akanuma; Y Yamaji; K Ogura; H Yoshida; Y Shiratori; M Omata
Journal:  Infect Immun       Date:  2001-06       Impact factor: 3.441

7.  Adenocarcinoma complicating columnar epithelium-lined (Barrett's) esophagus.

Authors:  R C Haggitt; J Tryzelaar; F H Ellis; H Colcher
Journal:  Am J Clin Pathol       Date:  1978-07       Impact factor: 2.493

8.  Rising incidence of adenocarcinoma of the esophagus and gastric cardia.

Authors:  W J Blot; S S Devesa; R W Kneller; J F Fraumeni
Journal:  JAMA       Date:  1991-03-13       Impact factor: 56.272

9.  Increasing incidence of adenocarcinoma of the gastric cardia and adjacent sites.

Authors:  J Powell; C C McConkey
Journal:  Br J Cancer       Date:  1990-09       Impact factor: 7.640

10.  Adenocarcinoma of the oesophagus and ectopic gastric mucosa.

Authors:  B C MORSON; J R BELCHER
Journal:  Br J Cancer       Date:  1952-06       Impact factor: 7.640

View more
  6 in total

Review 1.  Gastric carditis: Is it a histological response to high concentrations of luminal nitric oxide?

Authors:  Katsunori Iijima; Tooru Shimosegawa
Journal:  World J Gastroenterol       Date:  2006-09-28       Impact factor: 5.742

Review 2.  Stem Cell Pathology.

Authors:  Dah-Jiun Fu; Andrew D Miller; Teresa L Southard; Andrea Flesken-Nikitin; Lora H Ellenson; Alexander Yu Nikitin
Journal:  Annu Rev Pathol       Date:  2017-10-20       Impact factor: 23.472

Review 3.  Biomarkers in Barrett's esophagus and esophageal adenocarcinoma: predictors of progression and prognosis.

Authors:  Chin-Ann J Ong; Pierre Lao-Sirieix; Rebecca C Fitzgerald
Journal:  World J Gastroenterol       Date:  2010-12-07       Impact factor: 5.742

Review 4.  Role of the stem cell niche in the pathogenesis of epithelial ovarian cancers.

Authors:  Andrea Flesken-Nikitin; Ashley A Odai-Afotey; Alexander Yu Nikitin
Journal:  Mol Cell Oncol       Date:  2014-10-31

5.  De-repression of the RAC activator ELMO1 in cancer stem cells drives progression of TGFβ-deficient squamous cell carcinoma from transition zones.

Authors:  Heather A McCauley; Véronique Chevrier; Daniel Birnbaum; Géraldine Guasch
Journal:  Elife       Date:  2017-02-21       Impact factor: 8.140

6.  Single-cell analysis of gastric pre-cancerous and cancer lesions reveals cell lineage diversity and intratumoral heterogeneity.

Authors:  Jihyun Kim; Charny Park; Kwang H Kim; Eun Hye Kim; Hyunki Kim; Jong Kyu Woo; Je Kyung Seong; Ki Taek Nam; Yong Chan Lee; Soo Young Cho
Journal:  NPJ Precis Oncol       Date:  2022-01-27
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.